Ozempic maker to testify before Senate committee on weight loss drug prices

Washington — Lawmakers will question the maker of popular weight loss drugs Ozempic and Wegovy during a Senate committee hearing on Tuesday focused on what Sen. Bernie Sanders has called "outrageously high" prices Americans pay for the drugs. 

Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee, led by Sanders.

Sanders, a Vermont independent, told reporters on Monday that the hearing is about "simply asking Novo Nordisk why they continue to rip off the American people."